Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX – Get Free Report)’s share price crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $2.52 and traded as low as $0.80. Eagle Pharmaceuticals shares last traded at $1.30, with a volume of 565 shares traded.
Eagle Pharmaceuticals Trading Down 13.3%
The firm has a market cap of $16.88 million, a PE ratio of 1.10 and a beta of 0.83. The stock’s 50 day moving average price is $2.10 and its 200 day moving average price is $2.52.
Eagle Pharmaceuticals Company Profile
Eagle Pharmaceuticals, Inc, a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin’s lymphoma.
Featured Stories
- Five stocks we like better than Eagle Pharmaceuticals
- How to Use the MarketBeat Dividend Calculator
- Tesla Has Been Trapped in a 10% Range for Months—What’s Going On?
- How to trade using analyst ratings
- dLocal Falls Despite Blowout Q3 Results—What Investors Are Missing
- Insider Trades May Not Tell You What You Think
- Ondas Holdings Signals a Rebound as Drone Demand Soars
Receive News & Ratings for Eagle Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eagle Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
